Timo Oosenbrug

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Venues

Cellular & molecular immunology

The Journal of biological chemistry

The EMBO journal

Human gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Xin Lei, Daniël C de Groot, Marij J P Welters, Tom de Wit, Ellen Schrama, Hans van Eenennaam, Saskia J Santegoets, Timo Oosenbrug, Annemarthe G van der Veen, Joris L Vos, Charlotte L Zuur, Noel F C C de Miranda, Heinz Jacobs, Sjoerd H van der Burg, Jannie Borst, Yanling Xiao
CD4 + T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors. Cellular & molecular immunology 21 (4) (2024)
Xin Lei, Daniël C de Groot, Marij J P Welters, Tom de Wit, Ellen Schrama, Hans van Eenennaam, Saskia J Santegoets, Timo Oosenbrug, Annemarthe G van der Veen, Joris L Vos, Charlotte L Zuur, Noel F C C de Miranda, Heinz Jacobs, Sjoerd H van der Burg, Jannie Borst, Yanling Xiao
CD4 + T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors. Cellular & molecular immunology 21 (4) (2024)
Xin Lei, Daniël C de Groot, Marij J P Welters, Tom de Wit, Ellen Schrama, Hans van Eenennaam, Saskia J Santegoets, Timo Oosenbrug, Annemarthe G van der Veen, Joris L Vos, Charlotte L Zuur, Noel F C C de Miranda, Heinz Jacobs, Sjoerd H van der Burg, Jannie Borst, Yanling Xiao
CD4 + T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors. Cellular & molecular immunology 21 (4) (2024)
Xin Lei, Daniël C de Groot, Marij J P Welters, Tom de Wit, Ellen Schrama, Hans van Eenennaam, Saskia J Santegoets, Timo Oosenbrug, Annemarthe G van der Veen, Joris L Vos, Charlotte L Zuur, Noel F C C de Miranda, Heinz Jacobs, Sjoerd H van der Burg, Jannie Borst, Yanling Xiao
CD4 + T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors. Cellular & molecular immunology 21 (4) (2024)
Xin Lei, Daniël C de Groot, Marij J P Welters, Tom de Wit, Ellen Schrama, Hans van Eenennaam, Saskia J Santegoets, Timo Oosenbrug, Annemarthe G van der Veen, Joris L Vos, Charlotte L Zuur, Noel F C C de Miranda, Heinz Jacobs, Sjoerd H van der Burg, Jannie Borst, Yanling Xiao
CD4 + T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors. Cellular & molecular immunology (2024)
Xin Lei, Daniël C de Groot, Marij J P Welters, Tom de Wit, Ellen Schrama, Hans van Eenennaam, Saskia J Santegoets, Timo Oosenbrug, Annemarthe G van der Veen, Joris L Vos, Charlotte L Zuur, Noel F C C de Miranda, Heinz Jacobs, Sjoerd H van der Burg, Jannie Borst, Yanling Xiao
CD4 + T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors. Cellular & molecular immunology 21 (4) (2024)
Xin Lei, Daniël C de Groot, Marij J P Welters, Tom de Wit, Ellen Schrama, Hans van Eenennaam, Saskia J Santegoets, Timo Oosenbrug, Annemarthe G van der Veen, Joris L Vos, Charlotte L Zuur, Noel F C C de Miranda, Heinz Jacobs, Sjoerd H van der Burg, Jannie Borst, Yanling Xiao
CD4 + T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors. Cellular & molecular immunology (2024)
Xin Lei, Daniël C de Groot, Marij J P Welters, Tom de Wit, Ellen Schrama, Hans van Eenennaam, Saskia J Santegoets, Timo Oosenbrug, Annemarthe G van der Veen, Joris L Vos, Charlotte L Zuur, Noel F C C de Miranda, Heinz Jacobs, Sjoerd H van der Burg, Jannie Borst, Yanling Xiao
CD4 + T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors. Cellular & molecular immunology 21 (4) (2024)
Xin Lei, Daniël C de Groot, Marij J P Welters, Tom de Wit, Ellen Schrama, Hans van Eenennaam, Saskia J Santegoets, Timo Oosenbrug, Annemarthe G van der Veen, Joris L Vos, Charlotte L Zuur, Noel F C C de Miranda, Heinz Jacobs, Sjoerd H van der Burg, Jannie Borst, Yanling Xiao
CD4 + T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors. Cellular & molecular immunology 21 (4) (2024)
Jorn E Stok, Timo Oosenbrug, Laurens R Ter Haar, Dennis Gravekamp, Christian P Bromley, Santiago Zelenay, Caetano Reis E Sousa, Annemarthe G van der Veen
RNA sensing via the RIG-I-like receptor LGP2 is essential for the induction of a type I IFN response in ADAR1 deficiency. The EMBO journal 41 (6) (2022)
Timo Oosenbrug, Diana J M van den Wollenberg, Eline W Duits, Rob C Hoeben, Maaike E Ressing
Induction of Robust Type I Interferon Levels by Oncolytic Reovirus Requires Both Viral Replication and Interferon-α/β Receptor Signaling. Human gene therapy 32 (19-20) (2021)
Michel J van de Graaff, Timo Oosenbrug, Mikkel H S Marqvorsen, Clarissa R Nascimento, Mark A R de Geus, Bénédicte Manoury, Maaike E Ressing, Sander Izaäk van Kasteren
Conditionally Controlling Human TLR2 Activity via Trans-Cyclooctene Caged Ligands. Bioconjugate chemistry 31 (6) (2020)
Timo Oosenbrug, Michel J van de Graaff, Mariëlle C Haks, Sander Izaäk van Kasteren, Maaike E Ressing
An alternative model for type I interferon induction downstream of human TLR2. The Journal of biological chemistry 295 (42) (2020)

Timo Oosenbrug.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Timo Oosenbrug